An overview of parkinsonian syndromes: Data from the literature and from an Italian data-base

Sleep Medicine

Volumn 5, Issue 2, 2004, Pages 181-187

  Pezzoli, G ^a   Canesi, M ^a   Galli, C ^b  

^a PARKINSON INSTITUTE   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Data base; Disease progression; Neurodegenerative disease; Parkinson's disease; Parkinsonism

Indexed keywords

ALPHA SYNUCLEIN; APOMORPHINE; BENZAMIDE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CHLORPROMAZINE; FLUPENTIXOL; HALOPERIDOL; LEVODOPA; METOCLOPRAMIDE; PHENOTHIAZINE DERIVATIVE; SULPIRIDE; TAU PROTEIN; XANTHINE DERIVATIVE;

AKATHISIA; BRADYKINESIA; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DATA ANALYSIS; DATA BASE; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; GENE MUTATION; HUMAN; ITALY; MEDICAL LITERATURE; MEDICAL RESEARCH; MOLECULAR BIOLOGY; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RETROSPECTIVE STUDY; REVIEW; SHY DRAGER SYNDROME; SYNDROME; TAUOPATHY;

EID: 1542471805     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2003.10.009     Document Type: Article

References (29)

1. Golbe L.I. Neurodegeneration in the age of molecular biology Br Med J 324 2002 1467-1468
2. Gomez Tortosa E. Gonzalo I. Newell K. et al. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration Acta Neuropathol (Berlin) 103 5 2002 495-500
3. Yoshiyama Y. Lee V.M. Trojanovski J.Q. Frontotemporal dementia and tauopathy Curr Neurol Neurosci Rep 1 5 2001 413-421
4. Spillantini M.G. Schmidt M.L. Lee V.M. et al. Alpha-synuclein in Lewy bodies Nature 388 1997 839-840
5. Beirne G.J. Brennan J.T. Glomerulonephritis associated with hydrocarbon solvents; mediated by antiglomerular basement membrane antibody Wis Med J 72 4 1973 112
6. Quinn N. Parkinsonism-recognition and differential diagnosis Br Med J 310 1995 447-452
7. De Rijk M.C. Launer L.J. Berger K. et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts Neurology 54 Suppl. 5 2000 S21-S23
8. Sherer T.B. Betarbet R. Greenamyre J.T. Pathogenesis of Parkinson's disease Curr Opin Investig Drugs 2 2001 657-662
9. Stern M. Dulaney E. Gruber S.B. et al. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients Arch Neurol 48 9 1991 903-907
10. Boeve B.F. Silber M.H. Ferman T.J. et al. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy Mov Disord 16 4 2001 622-630
11. Arnulf I. Konofal E. Merino-Andreu M. et al. Parkinson's disease and sleepiness Neurology 58 2002 1019-1024
12. Pezzoli G. Canesi M. Antonini A. et al. Hydrocarbon exposure and Parkinson's disease Neurology 55 5 2000 667-673
13. Clarke C.E. Davies P. Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease J Neurol Neurosurg Psychiatry 69 5 2000 590-594
14. Gilman S. Low P. Quinn N. et al. Consensus statement on the diagnosis of multiple system atrophy Clin Auton Res 8 1998 359-362
15. Ghorayeb I. Yekhlef F. Chrysostome V. et al. Sleep disorders and their determinants in multiple system atrophy J Neurol Neurosurg Psychiatry 72 6 2002 798-800
16. Vanacore N. Bonifati V. Fabbrini G. et al. Epidemiology of multiple system atrophy. ESGAP consortium. European study group on atypical parkinsonisms Neurol Sci 22 1 2001 97-99
17. Horimoto Y. Aiba I. Yasuda T. et al. Longitudina MRI study of multiple system atrophy-when do the findings appear, and what is the course? J Neurol 249 7 2002 847-854
18. Taniwaki T. Nakagawa M. Yamada T. et al. Cerebral metabolic changes in early multiple system atrophy: a PET study J Neurol Sci 200 1/2 2002 79-84
19. Colosimo C. Pezzella F.R. The symptomatic treatment of multiple system atrophy Eur J Neurol 9 3 2002 195-199
20. Watanabe H. Saito Y. Terao S. et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients Brain 125 Pt 5 2002 1070-1083
21. Knopman D.S. An overview of common non-Alzheimer dementias Clin Geriatr Med 17 2 2001 281-301
22. Del Ser T. McKeith I. Anand R. et al. Dementia with Lewy bodies: findings from an international multicentre study Int J Geriatr Psychiatry 15 2000 1034-1045
23. McKeith I.G. Galasko D. Kosako K. et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 47 1996 1113-1124
24. McKeith I.G. Lewy body disease Rev Neurol 157 Suppl. 10 2001 28
25. Rajput A. Rajput A.H. Progressive supranuclear palsy. Clinical features, pathophysiology and management Drugs Aging 18 12 2001 913-925
26. Forman M.S. Zhukareva V. Bergeron C. et al. Signature tau neuropathology in gray and white matter of corticobasal degeneration Am J Pathol 160 6 2002 2047-2053
27. Stover N.P. Watts R.L. Corticobasal degeneration Semin Neurol 21 1 2001 49-58
28. Baldereschi M. Di Carlo A. Amaducci L. Epidemiology of dementias Drugs Today 34 1998 747-758
29. Koreczyn A.D. Dementia in Parkinson's disease J Neurol 248 Suppl. 3 2001 III/1-III/4